GRCE vs REG · $35.0M cap vs P/E 34, $12.93B cap
Grace Therapeutics, Inc. (GRCE) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
GRCE does not have a complete income-statement cache yet.
REG does not have a complete income-statement cache yet.
GRCE currently screens at market cap $35.0M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the GRCE and REG stock pages for the full models.
Not investment advice.